Literature DB >> 24176499

Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.

Kaatje Smits1, Gaelle Pottier1, Julie Smet1, Violette Dirix1, Françoise Vermeulen2, Iris De Schutter3, Maria Carollo4, Camille Locht5, Clara Maria Ausiello4, Françoise Mascart6.   

Abstract

To better understand vaccine-induced protection and its potential failure in light of recent whooping cough resurgence, we evaluated quantity as well as quality of memory T cell responses in B. pertussis-vaccinated preadolescent children. Using a technique based on flow cytometry to detect proliferation, cytokine production and phenotype of antigen-specific cells, we evaluated residual T cell memory in a cohort of preadolescents who received a whole-cell pertussis (wP; n=11) or an acellular pertussis vaccine (aP; n=13) during infancy, and with a median of 4 years elapsed from the last pertussis booster vaccine, which was aP for all children. We demonstrated that B. pertussis-specific memory T cells are detectable in the majority of preadolescent children several years after vaccination. CD4(+) and CD8(+) T cell proliferation in response to pertussis toxin and/or filamentous hemagglutinin was detected in 79% and 60% of the children respectively, and interferon-γ or tumor necrosis factor-α producing CD4(+) T cells were detected in 65% and 53% of the children respectively. Phenotyping of the responding cells showed that the majority of antigen-specific cells, whether defined by proliferation or cytokine production, were CD45RA(-)CCR7(-) effector memory T cells. Although the time since the last booster vaccine was significantly longer for wP-compared to aP-vaccinated children, their proliferation capacity in response to antigenic stimulation was comparable, and more children had a detectable cytokine response after wP- compared to aP-vaccination. This study supports at the immunological level recent epidemiological studies indicating that infant vaccination with wP induces longer lasting immunity than vaccination with aP-vaccines.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acellular pertussis vaccine; Bordetella pertussis; Bp; Children; FHA; Immune response; Memory T cell; PBMC; PT; SEB; Staphylococcus enterotoxin B; Whole-cell pertussis vaccine; aP; acellular pertussis; filamentous hemagglutinin; peripheral blood mononuclear cells; pertussis toxin; wP; whole-cell pertussis

Mesh:

Substances:

Year:  2013        PMID: 24176499     DOI: 10.1016/j.vaccine.2013.10.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

Review 1.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

Review 2.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

Review 3.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

4.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

5.  Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.

Authors:  Carlin Aloe; Martin Kulldorff; Barry R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

Review 6.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

7.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors:  Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

8.  Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.

Authors:  Tara Bancroft; Myles B C Dillon; Ricardo da Silva Antunes; Sinu Paul; Bjoern Peters; Shane Crotty; Cecilia S Lindestam Arlehamn; Alessandro Sette
Journal:  Cell Immunol       Date:  2016-05-14       Impact factor: 4.868

9.  Reining in the "100-day cough": unfinished business.

Authors:  Nicole Le Saux; Ian Gemmill
Journal:  CMAJ       Date:  2016-09-26       Impact factor: 8.262

10.  Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis.

Authors:  Claudia Guevara; Chengxian Zhang; Jennifer A Gaddy; Junaid Iqbal; Julio Guerra; David P Greenberg; Michael D Decker; Nicholas Carbonetti; Timothy D Starner; Paul B McCray; Frits R Mooi; Oscar G Gómez-Duarte
Journal:  Infect Dis (Lond)       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.